Quest Laboratories IPO description – Quest Laboratories is a pharma formulation manufacturer involved in manufacturing formulations across a wide range that includes the following: antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory drugs, diabetes drugs, antidepressants, and many more. The company manufactures a wide range of products making its tally approximately 250 units. These exist in the form of ethical, generic, and over-the-counter drugs (OTC). They also exist in the forms of tablets, liquid orals, oral dry powders, oral powder (ORS), ointment, and external liquids.
Quest Laboratories has the FDA and equivalent body approvals to manufacture over 600 formulations. Quest has regularly manufactured 250-300 types of formulations because of market trends and limited formulation lines. Sales orders have been coming from the private sector & government institutions eagerly. It has embarked on successful government tender contracts for the past few years with major state and central government institutions and corporations.
Based on sales made for the period ended 31 December 2023 and also for the FY 2023, 2022, and 2021, the company operates in the domestic market across 12 states and two union territories, namely; Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana and Bihar. As of 31 December 2023, Quest Laboratories’ registered office and manufacturing facility employ 84 individuals.
Promoters of Quest Laboratories – Mr. Anil Kumar Sabarwal, and Ms. Tejaswini Sabarwal
Table of Contents
Quest Laboratories IPO Details
| Quest Laboratories IPO Dates | 15 – 17 May 2024 |
| Quest Laboratories Issue Price | INR 93 – 97 per share |
| Fresh issue | 4,449,600 shares (INR 41.38 – 43.16 crore) |
| Offer For Sale | NIL |
| Total IPO size | 4,449,600 shares (INR 41.38 – 43.16 crore) |
| Minimum bid (lot size) | 1,200 shares (INR 116,400) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE EMERGE |
Quest Laboratories Financial Performance
| Â | FY 2021 | FY 2022 | FY 2023 | 9M FY 2024 |
| Revenue | 30.36 | 59.48 | 61.64 | 62.08 |
| Expenses | 29.65 | 53.78 | 54.91 | 51.03 |
| Net income | 0.66 | 4.11 | 5.03 | 7.75 |
Quest Laboratories Offer News
- Quest Laboratories RHP
- Quest Laboratories Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2024
Quest Laboratories Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 0.61 | 3.81 | 4.66 |
| PE ratio | – | – | 19.96 – 20.82 |
| RONW (%) | 11.12 | 41.08 | 33.74 |
| NAV | 5.46 | 9.26 | 13.93 |
| ROE (%) | 11.78 | 51.69 | 40.20 |
| EBITDA (%) | 4.67 | 10.87 | 12.69 |
| Debt/Equity | 0.52 | 0.31 | 0.27 |
Quest Laboratories IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 22 May 2024 | 63 | – | 55,000 |
| 21 May 2024 | 40 | – | 44,500 |
| 20 May 2024 | 25 | – | 37,500 |
| 18 May 2024 | 10 | – | 12,000 |
| 17 May 2024 | 5 | – | 7,000 |
| 16 May 2024 | 5 | – | 7,000 |
| 15 May 2024 | 7 | – | 8,000 |
Quest Laboratories IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 8,31,600 | 6,55,200 | 14,98,800 | 29,85,600 |
| 17 May 2024 | 57.20 | 184.45 | 57.62 | 85.34 |
| 16 May 2024 | 0.01 | 2.71 | 6.12 | 3.67 |
| 15 May 2024 | 0.01 | 0.73 | 2.05 | 1.19 |
The market maker reservation portion of 2,28,000 shares is not included in the above calculations.
Quest Laboratories IPO Allotment Status
Quest Laboratories IPO allotment status is now available on Bigshare Services’ website. Click on this link to get allotment status.
Quest Laboratories IPO Dates & Listing Performance
| Quest IPO Opening Date | 15 May 2024 |
| Quest IPO Closing Date | 17 May 2024 |
| Finalization of Basis of Allotment | 21 May 2024 |
| Initiation of refunds | 22 May 2024 |
| Transfer of shares to demat accounts | 22 May 2024 |
| Quest Laboratories IPO Listing Date | 23 May 2024 |
| Opening Price on NSE SME | INR 155.10 per share (up 59.90%) |
| Closing Price on NSE SME | INR 147.35 per share (up 51.91%) |
Quest Laboratories Offer Lead Manager
SHRENI SHARES LIMITED
Office No. 217, Hive 67 Icon, Poisar Gymkhana Road,
Lokmanya Tilak Nagar Poisar, Near Raghuleela Mall,
Kandivali West, Mumbai-400067, Maharashtra
Phone: 022 2089 7022
Email:Â [email protected]
Website:Â www.shreni.in
Quest Laboratories Offer Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East, Mumbai – 400 093
Phone:Â +91 22 6263 8200
Email:Â [email protected]
Website:Â www.bigshareonline.com
Quest IPO Contact Details
QUEST LABORATORIES LIMITED
Plot No. 45 Sector III Pithampur,
Dhar – 454775, Madhya Pradesh, India
Phone: 07292292374
E-mail: [email protected]
Website: www.questlabltd.com
IPO FAQs
What is the Quest Laboratories Issue size?
Quest Laboratories’ offer size is INR 41.38 – 43.16 crores.
What is the Quest Laboratories IPO price band?
Quest Laboratories’ public offer price is INR 93 – 97 per share.
What is the lot size of the Quest Laboratories Offer?
Quest Laboratories offer lot size is 1,200 shares.
What is Quest Laboratories IPO GMP today?
Quest Laboratories IPO GMP today is INR 63 per share.
What is the Quest Laboratories kostak rate today?
Quest Laboratories’ kostak rate today is INR NA per application.
What is Quest Laboratories Subject to the Sauda rate today?
Quest Laboratories is Subject to the Sauda rate today is INR 55,000 per application.
